Conservative Review with Daniel Horowitz cover image

Story of 2021: The War on Treatment That Killed Millions | Guest: Dr. Tess Lawrie | 12/17/21

Conservative Review with Daniel Horowitz

00:00

Ivomecton Is All Am

Ibemectan has been the subject of a major trial at Oxford University. The drug is being trialled in patients with an aggressive form of bowel cancer called acute myeloid leukemia (AML) But doctors have raised concerns about its safety and effectiveness. And now they've found out that it could be used to treat other forms of AML as well, says Dr Andrew Wakefield.

Play episode from 41:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app